Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 1/20 | 0.54 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 2/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128549 | 0.98 | NCF1 (0.56) | NCF1LOXL2MAPTALDH1A1HPGD | |
| Water SCHEMBL11636960 | 0.95 | NCF1 (0.54) | NCF1LOXL2MAPTALDH1A1HPGD | |
| SCHEMBL28195065 | 0.95 | NCF1 (0.54) | NCF1LOXL2MAPTALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL8722622 | 0.95 | NCF1 (0.54) | NCF1LOXL2MAPTALDH1A1HPGD | |
| SCHEMBL31139499 | 0.95 | NCF1 (0.54) | NCF1LOXL2MAPTALDH1A1HPGD | |
| SCHEMBL28398977 | 0.95 | NCF1 (0.54) | NCF1LOXL2MAPTALDH1A1HPGD | |
| Ammonia Solution, Strong SCHEMBL28083889 | 0.95 | NCF1 (0.54) | NCF1LOXL2MAPTALDH1A1HPGD | |
| Ethane SCHEMBL6176957 | 0.93 | NCF1 (0.52) | NCF1LOXL2MAPTALDH1A1HPGD | |
| Methyl Alcohol SCHEMBL8862947 | 0.93 | NCF1 (0.52) | NCF1LOXL2MAPTALDH1A1HPGD | |
| Formaldehyde SCHEMBL27745422 | 0.91 | NCF1 (0.50) | NCF1LOXL2MAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119432383-A | High-selectivity etching solution for radio frequency chip material | 湖北兴福电子材料股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2012068560-A3 | 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS | JENRIN DISCOVERY (US) | 2013-08-15 | — | — | WO | disclosed |
| CN-101474152-A | Mefloquine fat emulsion composition and method for preparing the same | UNIV NORTHWESTERN POLYTECHNIC (CN) | 2009-07-08 | — | — | CN | disclosed |
| US-20090124658-A1 | Treatments for Viral Infections | KELLER ROBERT H | 2009-05-14 | — | — | US | disclosed |
| US-7479498-B2 | Treatments for viral infections | PHOENIX BIOSCIENCES, INC. (US) | 2009-01-20 | — | — | US | disclosed |
| CN-101300249-A | Aminoquinoline and aminoquinazoline kinase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2008-11-05 | — | — | CN | disclosed |
| CN-101291922-A | Alkylquinoline and alkylquinazoline kinase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-22 | — | — | CN | disclosed |
| EP-1450803-A4 | NEW USES FOR ANTI-MALARIAL THERAPEUTIC AGENTS | CHAROUS LAUREN (US) | 2008-09-03 | — | — | EP | disclosed |
| CN-101243065-A | Intermediates for the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related synthetic methods | JANSSEN PHARMACEUTICA NV (BE) | 2008-08-13 | — | — | CN | disclosed |
| CN-1994466-A | Use of composition for treatment of viral infections | MP 1 INC (US) | 2007-07-11 | — | — | CN | disclosed |
| US-6734192-B1 | ADMINISTERING QUERCETIN OR DERIVATIVES THEREOF, WITH THE CHANNEL BLOCKER AND QUINOLINE FOR TREATMENT OF HIV INFECTION | MP-1 INC. | 2004-05-11 | — | — | US | disclosed |
| US-20030224008-A1 | Novel uses for anti-malarial therapeutic agents | APT PHARMACEUTICALS, LLC (US) | 2003-12-04 | — | — | US | disclosed |
| US-6572858-B1 | Treating inflammatory conditions including pulmonary diseases states, such as asthma using antimalarial agents via non-systemic administration; hydroxychloroquine via inhalation | APT PHARMACEUTICALS, LLC | 2003-06-03 | — | — | US | disclosed |
| WO-2003039546-A1 | NEW USES FOR ANTI-MALARIAL THERAPEUTIC AGENTS | CHAROUS LAUREN (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003039488-A2 | A METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE | CHAROUS LAUREN (US) | 2003-05-15 | — | — | WO | disclosed |
| CN-1399558-A | Treatment of viral infections | IMMUNE BALANCE TECHNOLOGIES CO (US) | 2003-02-26 | — | — | CN | disclosed |
| EP-1210116-A2 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF VIRAL INFECTIONS CONTAINING A CALCIUM CHANNEL BLOCKER AND A QUINOLINE | Immune Balance Technologies Limited Company (US) | 2002-06-05 | — | — | EP | disclosed |
| EP-1175216-A2 | ANTIMALARIAN AGENTS FOR THE TREATMENT OF ASTHMA | APT Pharmaceutical, L.L.C. (US) | 2002-01-30 | — | — | EP | disclosed |
| WO-2001013907-A2 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF VIRAL INFECTIONS CONTAINING A CALCIUM CHANNEL BLOCKER AND A QUINOLINE | IMMUNE BALANCE TECHNOLOGIES LIMITED COMPANY (US) | 2001-03-01 | — | — | WO | disclosed |
| WO-2000066107-A2 | ANTIMALARIAN AGENTS FOR THE TREATMENT OF ASTHMA | APT PHARMACEUTICALS, L.L.C. (US) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224008-A1 | Novel uses for anti-malarial therapeutic agents | IL5, CCL11, TSLP | NCF1 997/4885LOXL2 1795/4885MAPT 1812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.